• Boule Diagnostics faced component shortages that prevented instrument deliveries in the third quarter of 2026.
• Instrument sales fell 56.5% to 363 units, reflecting supply constraints and weak demand.
• Net sales declined 24.4% to SEK 96.2 million; adjusted operating loss reached SEK 4.5 million.
• The order backlog reached SEK 76 million, partly reflecting orders delayed by component shortages.
• Available liquidity totaled SEK 21.6 million; management and the board are evaluating options to strengthen the financial position.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boule Diagnostics AB published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.